| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0009 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |